Clinical Trials Browser

Phase 2/3 × Unknown × Thalidomide × Clear all

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

Phase 2/3 Unknown

Multiple Myeloma

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Phase 2/3 Unknown

NSCLC